Indirect estimation of a discrete‐state discrete‐time model using secondary data analysis of regression data

Multi-state models of chronic disease are becoming increasingly important in medical research to describe the progression of complicated diseases. However, studies seldom observe health outcomes over long time periods. Therefore, current clinical research focuses on the secondary data analysis of the published literature to estimate a single transition probability within the entire model. Unfortunately, there are many difficulties when using secondary data, especially since the states and transitions of published studies may not be consistent with the proposed multi-state model. Early approaches to reconciling published studies with the theoretical framework of a multi-state model have been limited to data available as cumulative counts of progression. This paper presents an approach that allows the use of published regression data in a multi-state model when the published study may have ignored intermediary states in the multi-state model. Colloquially, we call this approach the Lemonade Method since when study data give you lemons, make lemonade. The approach uses maximum likelihood estimation. An example is provided for the progression of heart disease in people with diabetes.

[1]  Alan Brennan,et al.  Computer Modeling of Diabetes and Its Complications , 2007, Diabetes Care.

[2]  S. Yusuf,et al.  Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry , 2000, Circulation.

[3]  R. Holman,et al.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.

[4]  N Urban,et al.  Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening. , 1997, Controlled clinical trials.

[5]  J. Habbema,et al.  Cost-effectiveness of cervical cancer screening. , 1983, Connecticut medicine.

[6]  Deanna J. M. Isaman,et al.  A computer simulation model of diabetes progression, quality of life, and cost. , 2005, Diabetes care.

[7]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[8]  V. Salomaa,et al.  Impact of Diabetes on Mortality After the First Myocardial Infarction , 1998, Diabetes Care.

[9]  Anke Richter,et al.  Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. , 2002, JAMA.

[10]  A. Yashin,et al.  Analyses of cohort mortality incorporating observed and unobserved risk factors , 1997 .

[11]  R. Holman,et al.  A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) , 2004, Diabetologia.

[12]  S. Johansson,et al.  Long-Term Prognosis After Myocardial Infarction in Men with Diabetes , 1985, Diabetes.

[13]  Milton C Weinstein,et al.  Empirically calibrated model of hepatitis C virus infection in the United States. , 2002, American journal of epidemiology.

[14]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[15]  W. Koenig,et al.  The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? , 2000, Diabetologia.

[16]  R. Holman,et al.  Life-expectancy projection by modelling and computer simulation (UKPDS 46). , 2000, Diabetes research and clinical practice.

[17]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[18]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[19]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[20]  Deanna J. M. Isaman,et al.  A discrete‐state discrete‐time model using indirect observation , 2006, Statistics in medicine.

[21]  R. Holman,et al.  Erratum: The UKPDS risk engine: A model for the risk of coronary heart disease in type II diabetes (UKPDS 56) (Clinical Science (2001) 101 (671-679)) , 2002 .

[22]  Theo Stijnen,et al.  Advanced methods in meta‐analysis: multivariate approach and meta‐regression , 2002, Statistics in medicine.

[23]  A. Yashin,et al.  Methods for combining ancillary data in stochastic compartment models of cancer mortality: generalization of heterogeneity models. , 1993, Mathematical population studies.

[24]  K. Manton,et al.  A stochastic compartment model representation of chronic disease dependence: techniques for evaluating parameters of partially unobserved age inhomogeneous stochastic processes. , 1980, Theoretical population biology.

[25]  S. Chick,et al.  A taxonomy of model structures for economic evaluation of health technologies. , 2006, Health economics.

[26]  Ping Zhang,et al.  Guidelines for computer modeling of diabetes and its complications , 2004 .